[ad_1]
The plea claimed that the representations of SMTA and different stakeholders weren’t thought-about on the time of taking the choice.
The court docket listed the matter for listening to with a petition moved final 12 months by SMTA difficult a notification which declared blood monitoring devices, digital thermometers, nebulizers and glucometers as ‘medicine’ beneath the Drugs and Cosmetics Act.
The bench mentioned each the issues will probably be heard on January 29, 2021.
SMTA, represented by advocate Adit S Pujari, has contended that the notification is unreasonable, arbitrary, and would trigger “undue hardship to stakeholders on the supply and demand side”.
In its earlier plea, the affiliation has mentioned that notifying the devices as medicine will end in a considerable hike of their costs which might make them unaffordable for a big phase of society.
(This story has not been edited by Newslivenation employees and is auto-generated from a syndicated feed.)